Today: 26 June 2026
SoFi (NASDAQ:SOFI) holds near $17 as AI trading faces Russell volume test
26 June 2026
2 mins read

SoFi (NASDAQ:SOFI) holds near $17 as AI trading faces Russell volume test

NEW YORK, June 26, 2026, 08:01 EDT

  • SoFi Technologies, Inc. (NASDAQ:SOFI) traded around $17.30 in premarket action after slipping 2.95% for the week.
  • The stock is still trading roughly 47% under its $32.73 high from Nov. 12, 2025, despite SoFi rolling out its AI investing platform this week.
  • Friday’s Russell index rebalancing could drive more volume than news about the products, with FTSE Russell estimating around $12.2 trillion tracks or uses its U.S. indexes.

SoFi Technologies, Inc. (NASDAQ:SOFI) heads into Friday with investors watching to see if index flows are the next driver for the stock, after a new AI trading product failed to move shares much. No rerate yet, and attention shifts away from headline risk for now.

Shares were little changed at around $17.30 ahead of the Nasdaq open. Wall Street starts regular trade at 9:30 a.m. Eastern, with pre-market quotes from 4:00 a.m. to 9:30 a.m. June 26 isn’t shown as a market holiday by Nasdaq.

SoFi is down 2.95% for the week but still shows a 4.98% gain over the month, TradingView data show. The stock has a beta of 2.47 and a market cap near $22.2 billion.

SoFi (NASDAQ:SOFI) is at $17.30, down about 47% from its Nov. 12, 2025 high of $32.73. The company has rolled out AI investing to its platform, but member, deposit, and fee growth haven’t pushed the stock higher.

SoFi on Tuesday said it launched Composer by SoFi after acquiring Composer Securities LLC. The firm said the platform lets users build, test, and run trading strategies using plain language. “If you can explain an investment idea in plain English, you can now build, test, and automate it,” CEO Anthony Noto told Reuters. Reuters

SoFi’s shares barely moved, with investors still treating the stock as a high-beta lender at a premium price. It’s not getting AI fee-revenue treatment in the market. SoFi trades at around 39 times trailing earnings, Robinhood and TradingView show.

FTSE Russell’s June reconstitution is due after the U.S. market close Friday. The index group said about $12.2 trillion is tied to its U.S. indexes, with $217.2 billion trading at the close during the June 2025 event.

Russell’s annual index reshuffle this year could see as much as $150 billion change hands, Reuters said Thursday. Steven DeSanctis, equity analyst at Jefferies, labeled it a “really massive trade” and described the turnover as “dramatic.” Reuters

SoFi is not at risk of missing the large-cap cutoff. Its market cap is far above the $5.7 billion line FTSE Russell sets between the Russell 1000 and Russell 2000. The question is if the last-hour index trades are just more noise for a stock that already swings at double the market’s beta.

SoFi’s results beat its stock this quarter. First-quarter adjusted net revenue came in at $1.1 billion, a 41% jump. Adjusted EBITDA hit $339.9 million, up 62%. Membership grew 35% to 14.7 million.

SoFi’s guidance is the issue. William Blair’s Andrew Jeffrey said after Q1 that SoFi “did not flow through first-quarter revenue and EBITDA upside.” Shares dropped 12% when the company held its 2026 forecast steady, according to Reuters.

Composer is a start, but it doesn’t close the gap yet. SoFi Invest finished Q1 with 3.7 million products, up 37% from last year, the company said. Brokerage fee revenue more than doubled. Now investors want to see if AI tools can lift fee revenue without stacking on the credit risk that keeps the stock tied to rates.

Jerzy Lewandowski is a senior markets editor at TS2.tech covering stocks, artificial intelligence, semiconductors and global financial markets. He studied economics at the University of Warsaw and previously worked in investment analysis before moving into financial journalism. His daily coverage focuses on the trends and events that matter most to investors worldwide.

Stock Market Today

  • Micron Shares Slide 5.4% Amid Peak Memory Market Concerns
    June 26, 2026, 9:13 AM EDT. Micron Technology's shares fell 5.4% in premarket trading on June 26, 2026, following a 15.7% surge the previous day. Despite strong fiscal Q3 results with $41.46 billion in revenue and $25.11 in non-GAAP EPS, traders questioned peak-memory market prospects. The stock traded at 9.3 times its fiscal Q4 EPS guidance of $31, a relatively low multiple for a chip giant amid uncertainties over contract price ceilings. Micron holds $100 billion in minimum-price revenue contracts with strategic customers, but price caps could restrict share gains if memory prices continue rising. CEO Sanjay Mehrotra noted no clear outlook on memory supply-demand balance. Nasdaq 100 futures also declined 1.25%, reflecting broader market caution.

Latest News

SoFi (NASDAQ:SOFI) holds near $17 as AI trading faces Russell volume test

SoFi (NASDAQ:SOFI) holds near $17 as AI trading faces Russell volume test

26 June 2026
SoFi shares hovered near $17.30 premarket, about 47% below last year’s high, as investors shrugged off this week’s AI investing platform launch and focused on Friday’s Russell index reconstitution, which could drive major trading volume and volatility, with $12.2 trillion tracking FTSE Russell indexes and nearly $150 billion in trades expected during the reshuffle, according to Reuters and lseg.com.
Micron shares slip as traders question peak-memory outlook

Micron shares slip as traders question peak-memory outlook

26 June 2026
Micron plunged 5.4% premarket after a record 15.7% rally, as investors weighed its low 9.3x forward earnings multiple and $100 billion in strategic customer deals with price ceilings that could cap upside if chip prices keep rising; fiscal Q4 revenue guidance hit $50 billion, but analysts split on whether contract limits restrict future gains.
Micron shares slip as traders question peak-memory outlook
Previous Story

Micron shares slip as traders question peak-memory outlook

MaaT Pharma (EPA:MAAT) CHMP rejection shifts attention to September appeal, cash runway
Next Story

MaaT Pharma (EPA:MAAT) CHMP rejection shifts attention to September appeal, cash runway

Go toTop